ABIO Annual Working Capital
$36.79 M
-$4.77 M-11.48%
31 December 2023
Summary:
As of February 5, 2025, ABIO annual working capital is $36.79 million, with the most recent change of -$4.77 million (-11.48%) on December 31, 2023. During the last 3 years, it has fallen by -$9.68 million (-20.82%).ABIO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABIO Quarterly Working Capital
$32.55 M
-$2.54 M-7.24%
30 June 2024
Summary:
As of February 5, 2025, ABIO quarterly working capital is $32.55 million, with the most recent change of -$2.54 million (-7.24%) on June 30, 2024. Over the past year, it has dropped by -$4.41 million (-11.92%).ABIO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABIO Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.5% | -11.9% |
| 3 y3 years | -20.8% | -42.4% |
| 5 y5 years | +514.9% | -42.4% |
ABIO Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -70.0% | -82.3% |
ARCA Biopharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $32.55 M(-7.2%) |
| Mar 2024 | - | $35.09 M(-5.0%) |
| Dec 2023 | $36.79 M(-11.5%) | $36.95 M(-2.5%) |
| Sept 2023 | - | $37.90 M(-3.2%) |
| June 2023 | - | $39.15 M(-3.2%) |
| Mar 2023 | - | $40.44 M(-2.7%) |
| Dec 2022 | $41.57 M(-18.4%) | $41.57 M(-2.5%) |
| Sept 2022 | - | $42.61 M(-5.0%) |
| June 2022 | - | $44.85 M(-6.2%) |
| Mar 2022 | - | $47.82 M(-6.1%) |
| Dec 2021 | $50.92 M(+9.6%) | $50.92 M(-9.8%) |
| Sept 2021 | - | $56.48 M(-7.6%) |
| June 2021 | - | $61.10 M(-7.2%) |
| Mar 2021 | - | $65.85 M(+41.7%) |
| Dec 2020 | $46.47 M(+515.2%) | $46.47 M(-7.8%) |
| Sept 2020 | - | $50.41 M(+392.0%) |
| June 2020 | - | $10.24 M(+64.6%) |
| Mar 2020 | - | $6.22 M(-17.6%) |
| Dec 2019 | $7.55 M(+26.2%) | $7.55 M(-13.7%) |
| Sept 2019 | - | $8.75 M(-4.1%) |
| June 2019 | - | $9.12 M(+26.2%) |
| Mar 2019 | - | $7.23 M(+20.8%) |
| Dec 2018 | $5.98 M(-41.5%) | $5.98 M(-19.3%) |
| Sept 2018 | - | $7.41 M(-17.2%) |
| June 2018 | - | $8.95 M(-18.7%) |
| Mar 2018 | - | $11.01 M(+7.6%) |
| Dec 2017 | $10.23 M(-46.3%) | $10.23 M(-26.0%) |
| Sept 2017 | - | $13.83 M(-2.2%) |
| June 2017 | - | $14.14 M(-18.5%) |
| Mar 2017 | - | $17.34 M(-9.0%) |
| Dec 2016 | $19.05 M(-49.1%) | $19.05 M(-11.9%) |
| Sept 2016 | - | $21.63 M(-13.6%) |
| June 2016 | - | $25.04 M(-12.7%) |
| Mar 2016 | - | $28.67 M(-23.4%) |
| Dec 2015 | $37.41 M(+165.3%) | $37.41 M(-7.4%) |
| Sept 2015 | - | $40.38 M(-6.0%) |
| June 2015 | - | $42.97 M(+272.3%) |
| Mar 2015 | - | $11.54 M(-18.1%) |
| Dec 2014 | $14.10 M(-8.6%) | $14.10 M(-15.2%) |
| Sept 2014 | - | $16.63 M(-9.9%) |
| June 2014 | - | $18.46 M(-10.7%) |
| Mar 2014 | - | $20.68 M(+34.1%) |
| Dec 2013 | $15.42 M(+462.9%) | $15.42 M(-15.5%) |
| Sept 2013 | - | $18.24 M(-8.4%) |
| June 2013 | - | $19.91 M(+529.0%) |
| Mar 2013 | - | $3.17 M(+15.5%) |
| Dec 2012 | $2.74 M(-49.8%) | $2.74 M(-8.0%) |
| Sept 2012 | - | $2.98 M(-2.7%) |
| June 2012 | - | $3.06 M(-25.5%) |
| Mar 2012 | - | $4.11 M(-24.7%) |
| Dec 2011 | $5.46 M(-8.6%) | $5.46 M(+0.6%) |
| Sept 2011 | - | $5.43 M(-20.5%) |
| June 2011 | - | $6.82 M(+74.2%) |
| Mar 2011 | - | $3.92 M(-34.4%) |
| Dec 2010 | $5.97 M | $5.97 M(-24.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $7.87 M(-19.8%) |
| June 2010 | - | $9.80 M(-13.4%) |
| Mar 2010 | - | $11.32 M(+79.3%) |
| Dec 2009 | $6.31 M(-202.6%) | $6.31 M(-29.7%) |
| Sept 2009 | - | $8.98 M(+49.0%) |
| June 2009 | - | $6.03 M(-72.8%) |
| Mar 2009 | - | $22.18 M(-460.5%) |
| Dec 2008 | -$6.15 M(-107.5%) | -$6.15 M(-113.2%) |
| Sept 2008 | - | $46.57 M(-16.0%) |
| June 2008 | - | $55.45 M(+8.1%) |
| Mar 2008 | - | $51.27 M(-37.3%) |
| Dec 2007 | $81.80 M(-33.2%) | $81.80 M(-11.8%) |
| Sept 2007 | - | $92.73 M(-16.7%) |
| June 2007 | - | $111.37 M(+3.7%) |
| Mar 2007 | - | $107.37 M(-12.3%) |
| Dec 2006 | $122.50 M(+147.1%) | $122.50 M(-19.6%) |
| Sept 2006 | - | $152.28 M(-9.7%) |
| June 2006 | - | $168.70 M(-8.4%) |
| Mar 2006 | - | $184.12 M(+271.3%) |
| Dec 2005 | $49.58 M(+14.3%) | $49.58 M(-3.7%) |
| Sept 2005 | - | $51.48 M(-31.8%) |
| June 2005 | - | $75.47 M(-23.0%) |
| Mar 2005 | - | $98.04 M(+126.0%) |
| Dec 2004 | $43.38 M(+68.3%) | $43.38 M(-19.2%) |
| Sept 2004 | - | $53.66 M(-17.4%) |
| June 2004 | - | $64.95 M(-14.6%) |
| Mar 2004 | - | $76.09 M(+195.2%) |
| Dec 2003 | $25.77 M(-224.3%) | $25.77 M(-481.8%) |
| Sept 2003 | - | -$6.75 M(-263.6%) |
| June 2003 | - | $4.13 M(-68.8%) |
| Mar 2003 | - | $13.20 M(-163.7%) |
| Dec 2002 | -$20.73 M(+1107.2%) | -$20.73 M(+557.8%) |
| Sept 2002 | - | -$3.15 M(-0.9%) |
| June 2002 | - | -$3.18 M(-68.7%) |
| Mar 2002 | - | -$10.17 M(+492.3%) |
| Dec 2001 | -$1.72 M(-33.4%) | -$1.72 M(-121.2%) |
| Sept 2001 | - | $8.09 M(-912.7%) |
| June 2001 | - | -$996.00 K(-111.6%) |
| Mar 2001 | - | $8.58 M(-432.8%) |
| Dec 2000 | -$2.58 M(-111.7%) | -$2.58 M(-155.2%) |
| Sept 2000 | - | $4.67 M(-55.4%) |
| June 2000 | - | $10.47 M(-34.5%) |
| Mar 2000 | - | $15.99 M(-27.7%) |
| Dec 1999 | $22.10 M(-47.8%) | $22.10 M(-19.9%) |
| Sept 1999 | - | $27.60 M(-15.1%) |
| June 1999 | - | $32.50 M(-11.7%) |
| Mar 1999 | - | $36.80 M(-13.0%) |
| Dec 1998 | $42.30 M(-25.5%) | $42.30 M(-1.2%) |
| Sept 1998 | - | $42.80 M(-12.7%) |
| June 1998 | - | $49.00 M(-7.9%) |
| Mar 1998 | - | $53.20 M(-6.3%) |
| Dec 1997 | $56.80 M(+846.7%) | $56.80 M(-7.2%) |
| Sept 1997 | - | $61.20 M(+423.1%) |
| June 1997 | - | $11.70 M(+192.5%) |
| Mar 1997 | - | $4.00 M |
| Dec 1996 | $6.00 M | - |
FAQ
- What is ARCA biopharma annual working capital?
- What is the all time high annual working capital for ARCA biopharma?
- What is ARCA biopharma annual working capital year-on-year change?
- What is ARCA biopharma quarterly working capital?
- What is the all time high quarterly working capital for ARCA biopharma?
- What is ARCA biopharma quarterly working capital year-on-year change?
What is ARCA biopharma annual working capital?
The current annual working capital of ABIO is $36.79 M
What is the all time high annual working capital for ARCA biopharma?
ARCA biopharma all-time high annual working capital is $122.50 M
What is ARCA biopharma annual working capital year-on-year change?
Over the past year, ABIO annual working capital has changed by -$4.77 M (-11.48%)
What is ARCA biopharma quarterly working capital?
The current quarterly working capital of ABIO is $32.55 M
What is the all time high quarterly working capital for ARCA biopharma?
ARCA biopharma all-time high quarterly working capital is $184.12 M
What is ARCA biopharma quarterly working capital year-on-year change?
Over the past year, ABIO quarterly working capital has changed by -$4.41 M (-11.92%)